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Abstract
In this study we used differentiated adult human upcyte
1
cells for the in vitro generation of
liver organoids. Upcyte
1
cells are genetically engineered cell strains derived from primary
human cells by lenti-viral transduction of genes or gene combinations inducing transient
proliferation capacity (upcyte
1
process). Proliferating upcyte
1
cells undergo a finite number
of cell divisions, i.e., 20 to 40 population doublings, but upon withdrawal of proliferation stim-
ulating factors, they regain most of the cell specific characteristics of primary cells. When a
defined mixture of differentiated human upcyte
1
cells (hepatocytes, liver sinusoidal endo-
thelial cells (LSECs) and mesenchymal stem cells (MSCs)) was cultured in vitro on a thick
layer of Matrigel™, they self-organized to form liver organoid-like structures within 24 hours.
When further cultured for 10 days in a bioreactor, these liver organoids show typical func-
tional characteristics of liver parenchyma including activity of cytochromes P450, CYP3A4,
CYP2B6 and CYP2C9 as well as mRNA expression of several marker genes and other
enzymes. In summary, we hereby describe that 3D functional hepatic structures composed
of primary human cell strains can be generated in vitro. They can be cultured for a pro-
longed period of time and are potentially useful ex vivomodels to study liver functions.
Introduction
The idea to construct in vitro 3D tissue-like structures to be used as model system for the
respective organ is an appealing experimental approach. The main focus hereby is to exploit
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the in vivo physiological mechanism that occurs during organ development or healing (regen-
eration) and to implement similar mechanisms to develop a functional tissue in vitro. Such 3D
liver-like structures would for example meet the needs of the pharmacological and toxicological
industry for drug screening [1]. The main techniques to generate 3D cellular constructs are
either the formation of spheroids or building of tissue-like structures by placing sheets of cells
and extracellular matrix components on top of each other (reviewed in [2]). The disadvantage
of spheroids is that the cells are distributed randomly without formation of spatial organization
i.e., liver spheroids neither possess typical hepatic cord-like alignment of polarized hepatocytes
nor sinusoids lined with endothelial cells reflecting the in vivo situation. Similarly, 3D liver
models generated using sandwich cultures can never fully recapitulate the true in vivo architec-
ture of the organ. Such ex vivo formation of tissue for most complex organs such as heart, kid-
ney or brain would be very challenging. However, the liver is exceptional in its ability to
regenerate. It is well established that fully differentiated adult liver is capable of regeneration as
long as a sufficient amount of intact liver remains after damage (reviewed in [3] and [4]).
Therefore, in principle any differentiated adult liver cell should harbor the potential to prolifer-
ate and regenerate to a complex and functional organ under suitable conditions. Indeed,
Takebe and colleagues described recently that induced-pluripotent stem cells (iPSC) stimulated
to become hepatic endoderm-like cells (iPSC-HE) together with mesenchymal stem cells
(MSC) and human umbilical vein endothelial cells (HUVEC), self-organized in vitro into mac-
roscopically visible 3D cell clusters by an intrinsic organizing capacity [5]. When these struc-
tures were transplanted into mice, they became vascularized, engrafted into the recipient’s
tissue and produced hepatic factors like albumin. Possible applications of such an organoid
structure include replacement therapy but also the possibility to study hepatotoxic effects of
new compounds. They could as well be used as simplified model system to investigate pro-
cesses like liver regeneration, fibrogenesis or malignant transformation. Due to the fact that
these organoids are formed out of different cell types, which are in 3D contact to each other,
they can be expected to represent a system which is much closer to the depicted in vivo situa-
tion than conventional approaches.
In the present work we analyzed if liver organoids could also be generated from adult, differ-
entiated cells and if these organoids can be cultured for long-term to study liver functions.
Instead of stem cells, upcyte
1
hepatocytes were used to reflect the parenchymal cells of the
liver. In order to depict the native physiological condition of liver, we further used upcyte
1
liver sinusoidal endothelial cells (LSECs) instead of conventional endothelial cells like
HUVECs. LSECs are a specialized type of scavenger endothelial cells that are able to endocy-
tose an array of physiological and foreign macromolecules and colloids from the blood [6]. The
upcyte
1
process involves stable transduction of primary cells with lentiviral constructs carrying
sequences which code for certain proliferation-inducing factors. These cells are cultured in
medium containing a defined mixture of growth factors, allowing tighter control over prolifer-
ation (up to 40 population doublings) [7], [8]. Employing this process, almost unlimited num-
bers of cells from one donor can be obtained. The performance of upcyte1 hepatocytes
compared to primary cells has been extensively studied and it was demonstrated that these
cells are highly similar to primary cells [9], [10].
Our results show that by using upcyte
1
cells, liver organoids can be generated and these
organoids after culturing them for a period of 10 days, express several marker proteins, genes
and enzymes to a degree that is comparable to adult human liver. Furthermore, the architecture
of these liver organoids to some degree resembles typical hepatic structures. Potential future
applications of such in vitro generated hepatic organoids include pre-clinical drug screening or
investigation of liver injury processes like fibrogenesis, cirrhosis or inflammation prior to ani-
mal studies, or even as a replacement for animal studies.
Generation of 3D Liver Organoids
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Materials and Methods
Materials
Human upcyte
1
hepatocytes, upcyte
1
LSECs and upcyte
1
MSCs, upcyte
1
Hepatocyte Growth
Medium and upcyte
1
High Performance Medium, upcyte
1
LSEC Medium were fromMedicyte
GmbH, Heidelberg, Germany. Liver tissue was obtained from Tissue Solutions, Glasgow, UK.
The tissue provider holds the required ethics approvals in place, and ensures that it has copies
of this and their patient consent forms. Copies of sources Ethics approval and template donor
consent forms are available on request. Foetal bovine serum was obtained from PAN GmbH,
Aidenbach, Germany. BD Matrigel™ Basement Membrane Matrix was from Corning. Testos-
terone, 6β-hydroxytestosterone, and 40,6-diamidino-2-phenylindole (DAPI) were from Sigma-
Aldrich, Germany. CD31 antibodies were from DAKO, Eching, Germany. Mouse anti-Ck8
(C51), mouse anti-Ck18 (DC–10) and vimentin (E–5) were from Santa Cruz Biotechnology,
Heidelberg, Germany. Rabbit anti-albumin from Sigma, Mouse anti-E-Cadherin from BD
Transduction Laboratories, Alexa Fluor 546 goat anti-rabbit and Alexa Fluor 488 goat anti-
mouse from Invitrogen were used for immunofluorescence staining. Nuclei were counter-
stained with Draq5 from BioStatus. Cy3 goat anti-mouse IgG was from Dianova, Hamburg,
Germany. All other chemicals and media are either mentioned in the corresponding text below
or were obtained from standard commercial suppliers. The primary human hepatocytes used
for the upcyte1 process (see below) were initially purchased from Cellzdirect/Life
Technologies.
Cell culture and liver organoid formation
The upcyte
1
process was performed according to Burkard et al., 2012 [8] and Levy et al. [9].
Cells were cultured at 37°C, 5% CO2 and 95% humidity. The cells were passaged at 70–80%
confluence and living cells were counted using Trypan Blue exclusion. For the generation of
liver organoids, required culture plates, bioreactors and pipette tips were pre-cooled at 4°C
before use and Matrigel™ was thawed overnight at 4°C. Matrigel™ was diluted 1:1 with upcyte
1
LSEC Growth Medium. For generation of one liver organoid in a 24-well format or in the bio-
reactors, 380 μl of diluted Matrigel™ (~200 μl/cm2) was added to the plates/chambers and incu-
bated at 37°C for 30 to 45 minutes to allow for polymerization. Trypsinized cells were re-
suspended in liver organoid growth medium (upcyte
1
Hepatocyte Growth Medium and
upcyte
1
LSEC Growth Medium in 1:1 ratio). 1.0 x106 upcyte
1
hepatocytes (from the Donor
No. 422A-03), 1.0 x106 upcyte
1
LSECs and 0.2 x106 upcyte
1
MSCs were mixed in 1 ml of liver
organoid growth medium, added to the Matrigel™-coated plates/chambers and further incu-
bated at 37°C, 5% CO2 and 95% humidity for the formation of liver organoids. We tested two
setups of bio-reactors, the Quasi-vivo
1
System from Kirkstall and the Live-box 1 system, devel-
oped by the group of Prof. Arti Ahluwalia, Faculty of Engineering University of Pisa, Italy
(IVTech srl, Lucca, Italy).
In situ hybridization
Detection of mRNA transcripts in paraffin sections was performed as described previously
[11],[12]. The protocol is based on the preparation of double-stranded DNA in vitro transcrip-
tion templates using polymerase chain reaction (PCR), with primers that include RNA poly-
merase promoter sequences and size-based purification of PCR fragments containing the
target gene-specific cDNA and promoter elements for T7 and SP6 RNA polymerase. The
primer sequences used are listed in Table 1.
Generation of 3D Liver Organoids
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CYP assay
For measurement of CYP activities (CYP2B6, 2C9 and 3A4), the liver organoids cultured for
10 days were incubated with each of the substrate separately. The substrates used were bupro-
pion-HCl, tolbutamide and testosterone to assess CYP2B6, 2C9 and 3A4 activities respectively.
The samples were transferred to a fresh 96-well plate and processed for HPLC analysis accord-
ing to Burkhard et al. [8]. The metabolites were analysed using UV-HPLC. For tolbutamide,
bupropion and their metabolites, 0.1 mg/ml chlorpropamide was used as internal standard.
For testosterone and its metabolite, 0.5 mM cortexolone was used as internal standard. The
mobile phases used for tolbutamide, bupropion and its metabolites were (A) 1.36 g KH2PO4 in
800 ml cell culture grade distilled water made up to 1 l (pH 4.6), 52.6 ml 100% acetonitrile and
(B) 500:500 acetonitrile:water. The mobile phases for testosterone and its metabolites were (A)
390:600:10 methanol:water:acetonitrile and (B) 800:180:20 methanol:water:acetonitrile. All the
metabolites and its respective internal standard were separated on a SunFire C18 2.5 μm
2.1×20 mm column (Waters, Munich, Germany). The peaks were detected on an UV detector
set to 200/229 nm for tolbutamide, bupropion and 252 nm for testosterone.
Immunocytochemistry
Cells were first fixed with 4% PFA for 5 min at RT, then rehydrated for 60 min using 3% bovine
serum albumin (BSA) in PBS. Cells were incubated for 45 min with the primary antibody
diluted in 0.2% BSA/PBS to detect CD31 (1:300), vimentin (1:200) or cytokeratin 8/18 (1:50).
After washing, the secondary antibodies Cy3™- conjugated AffiniPure goat anti-mouse IgG
(1:200, Jackson Immuno Research, Baltimore, USA) diluted (1:200) in 0.2% BSA/PBS contain-
ing DAPI (final conc. 300 nM) were incubated for 45 min at 37°C. Finally, the samples were
washed three times with 0.2% BSA/PBS and observed using phase contrast microscopy.
Immunohistochemistry
Immunoperoxidase-based immunohistochemistry was performed to stain 2 μm sections of
paraffin-embedded liver organoids. The following primary antibodies were used: mouse anti
human CK8/18 (monoclonal, concentrated, pH6; BD Pharmingen, San Jose, CA, USA), rabbit
anti human Vimentin (monoclonal, 1:400, pH6; Thermo scientific, Waltham, MA, USA),
mouse anti human CD31 (monoclonal, 1:500, pH9; DAKO), mouse anti human E-Cadherin
(monoclonal, 1:50, pH9, Thermo scientific), mouse anti human Ki67 (monoclonal, 1:800, pH6,
DAKO); Immunohistochemistry was performed as described in detail elsewhere [13] using the
following chemicals and reagents: antigen retrieval in Novocastra antigen retrieval solution
pH6 or pH 9.0 (Leica, Wetzlar, Germany); blocking of endogenous peroxidase (DAKO block-
ing solution, DAKO, Hamburg, Germany); detection of bound antibodies by the immunoper-
oxidase/DAB-based DAKO REAL detection system (DAKO). For immunofluorescence
Table 1. Gene specific sequences of the primers used for in situ hybridizations.
Gene name NCBI Ref. Seq. Forward Reverse
KRT18 NM_000224.2 GGTCAGAGACTGGA-GCCATTACTT CCAGCTTGACCTTGAT-GTTCAGCAG
Albumin NM_000477.5 GGTGAGACCAGAGG-TTGATGTGATG CACACATAACTGGTTC-AGGACCACG
Glutaminase2 NM_013267.2 GTGTGTGAGCAGCA-ACATTGTGCTC GATGGCTCCTGATACA-GCTGACTTG
Glutamine synthetase NM_001033044.2 GTTGCCTGAGTGGA-ATTTCGATGGC CGGTTTCATTGAGAAG-ACACGTGCG
HIF1α NM_001243084.1 CATGGAAGGTATTG-CACTGCACAGG CAGCACTACTTCGAAG-TGGCTTTGG
G6P NM_000151.2 GTGGCGTATCATGC-AAGTGCTATGC GAGGCTGAGACATGA-GAATCGCTTG
doi:10.1371/journal.pone.0139345.t001
Generation of 3D Liver Organoids
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staining, liver organoid sections were incubated overnight (37°C) with primary antibodies,
mouse anti-E-Cadherin (1:100) and rabbit anti-albumin (1:500) or non-immune IgGs diluted
in blocking buffer, washed and incubated with secondary antibodies in blocking buffer for 1 h
at room temperature. Nuclear stain was Draq5 (diluted 1:1000 in PBS). Sections were analysed
in a Zeiss LSM 510 confocal laser scanning microscope (Carl Zeiss, Germany).
RNA isolation and real-time PCR
Total RNA was isolated from liver organoids using “high pure RNA isolation kits” from Roche
including on column genomic DNA digestion with RNase free DNase (Mannheim, Germany).
1 μg total RNA was reverse transcribed to cDNA using the "Transcriptor First Strand cDNA
Synthesis Kit from Roche. For quantitative real-time PCR (using SyberGreen) for the detection
of expressions of drug metabolizing enzymes "Prime PCR assays and controls" from BioRad
(München, Germany) were used. For the detection of albumin, E-Cadherin and ZO–1 the fol-
lowing primers were used: ZO–1 F: 5'-ACCAGTAAGTCGTCCTGATCC–3'; R: 5'-TCGG
CCAAATCTTCTCACTCC–3'; E-Cadherin F: 5'-TGAAGGTGACAGAGCCTCTGGAT–
3'; R: 5'-TGGGTGAATTCGGGCTTGTT–3'; Albumin F: 5'-CTTGAATGTGCTGATG
ACAGG–3'; R: 5'-GCAAGTCAGCAGGCATCTCAT–3'. Data were analyzed using the ΔCt
method and expression values were normalized to the expression levels of the house-keeping
gene HPRT1 as indicated.
Results
Spontaneous self-assembly of liver organoids using upcyte1 cells
In order to generate liver organoids we used three different upcyte1 cell types (all human):
hepatocytes, liver sinusoidal endothelial cells (LSECs) and mesenchymal stem cells (MSCs). Fig
1 shows the typical morphology of these cells in monolayer culture and the presence of cell-
type specific marker proteins.
When plated on Matrigel™-coated 24-well plates, defined mixtures of these three cell types
self-assembled into a compact organoid structure (Fig 2A). In order to test if this process can
be downscaled to formats commonly used in industrial settings, i.e. 48 and 96 well plates, cell
number, medium and Matrigel™ volumes were reduced according to the surface area, which
still resulted in formation of organoids (S1 Fig). To avoid any nutrient or oxygen-deficiency,
liver organoids generated under static conditions (in the bioreactors) were connected to a
dynamic system after 24 h and constantly perfused with medium for 10 days. We tested two
setups of bio-reactors, the Quasi-vivo
1
System from Kirkstall and the Livebox 1 system, devel-
oped by the group of Prof. Arti Ahluwalia, Faculty of Engineering University of Pisa, Italy
(IVTech srl, Lucca, Italy) (Fig 2B and 2C). In both systems macroscopically similar liver orga-
noids formed within a comparable time. H&E staining of samples from both systems were
compared and in both no strong necrosis was observed (in contrast to static conditions for
more than 72h, data not shown). For all further experiments the Kirkstall system was used.
Spatial distribution of the diverse cell types within the organoids
In order to determine the individual localization of the three different cell types at early and
late stages of organoid formation, immunohistochemical stainings using antibodies against
cell-type specific marker proteins were performed (Fig 3). The results demonstrate that the dif-
ferent cell types are not simply randomly distributed within the organoid but that they rapidly
start to form structures with reproducible spatial distribution of hepatocytes and LSECs.
Upcyte
1
hepatocytes arranged in closely adherent clusters and moved towards the periphery of
Generation of 3D Liver Organoids
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Fig 1. Appearance of the cells used for organoid formation. Phase contrast photographs and immuno-fluorescent stainings for specific cell type markers
in the three different types of upcyte
1
cells which were used for liver organoid generation. CK: Cytokeratin.
doi:10.1371/journal.pone.0139345.g001
Fig 2. Generation of liver organoids in vitro. (A) Time-dependent formation of liver organoids in 24-well plates. Long-term culture (>48h) was performed in
a dynamic system, e.g. the quasi vivo system from kirkstall
1
(B) or the Live-box 1 system, generated by the group of Prof. Arti Ahluwalia, Faculty of
Engineering, University of Pisa, Italy (C).
doi:10.1371/journal.pone.0139345.g002
Generation of 3D Liver Organoids
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the liver organoid forming parenchymal areas while CD31-positive upcyte
1
LSECs were
mainly localized at the central regions. By contrast, MSCs (stained for vimentin) were distrib-
uted randomly between hepatocytes and LSECs.
Hepatocytes inside the organoid express mRNA for typical markers as
well as for many hepatic enzymes and they show typical liver
morphology
In an attempt to further characterize the functional status of the hepatocytes within the orga-
noids, we performed in situ hybridizations on serial paraffin sections of organoids from early
and late stages. The results demonstrate that hepatocytes within the organoid retain a constitu-
tive expression level of typical markers (e.g. cytokeratin 8 and 18) as well as important func-
tional hepatic genes like albumin or enzymes of the glutamine and glucose-metabolism (Fig 4).
To further investigate the functionality and polarity of the hepatocytes within the organoids
immunofluorescent double-staining of the epithelial marker protein E-Cadherin and albumin
was performed in 10-day liver organoids and was directly compared to adult human liver (Fig
5A). The presence and membraneous localization of E-Cadherin was further confirmed by
Fig 3. Spatial distribution of the different cell types within the liver organoids. H&E- and immuno-stainings for cell-type markers were performed in
serial sections of liver organoids (LO) after 72h and 10 days of culture. The scale bars for the original magnification of 200x equals 200 μm, that of the original
magnification of 100x equals 500 μm.
doi:10.1371/journal.pone.0139345.g003
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immunohistochemistry (Fig 5B). On the mRNA level expressions of E-Cadherin, albumin and
the cell-cell contact protein zona occludens 1 (ZO–1) were analyzed by real-time PCR and
compared to primary human hepatocytes or whole liver from a total of four different donors
(Fig 5C). In adult, differentiated liver cell proliferation is a rare event (see arrows in Fig 5B,
lower right picture). In 10-day liver organoids in contrast we found strong positive staining for
the proliferation marker Ki67 (Fig 5B, lower left picture) indicating that such organoids did
not yet reach a fully differentiated, quiescent status. In summary these data indicate that at
least some portion of the hepatocytes within the liver organoids express polarity markers
(E-Cadherin and ZO–1) and synthesize albumin to a degree which is comparable to adult
human liver or primary human hepatocytes.
Hepatocytes inside the organoids express drug metabolizing enzymes
To further investigate if hepatocytes show functional properties of liver parenchymal cells, liver
organoids were analyzed for basal activity of three prototypic CYPs, CYP-3A4, -2B6 and 2C9.
CYP3A4 is an enzyme that metabolizes a large number of clinically important substrates [14].
Drugs metabolized mainly by CYP2B6 include artemisinin, bupropion, cyclophosphamide,
efavirenz, ketamine, and methadone [15] while CYP2C9 is the principal isoform of the CYP2C
subfamily in the human liver and is involved in the oxidation of several endogenous and xeno-
biotic compounds, including many therapeutic drugs [16]. The results show that hepatocytes
within the liver organoids produce all these 3 enzymes. The basal activity levels were very com-
parable to that of the primary human hepatocytes which were initially used to generate the
Fig 4. Expression of functional genes and hepatocyte markers on the RNA level.mRNA transcripts of the indicated genes were detected by in situ
hybridization in serial sections of liver organoids (LO) after 72h and 10 days of culture.
doi:10.1371/journal.pone.0139345.g004
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Fig 5. Immunostainings of a 10-day liver organoid in comparison with adult human liver. A) Immunofluorescent staining for the epithelial marker
protein E-Cadherin (green) and the functional marker protein albumin (red) in a 10-day LO on the left and a cross-section of adult human liver on the right.
The scale bar equals 10 μm. B) Immunohistochemical stainings for E-Cadherin and the proliferation marker Ki67 in a 10-day liver organoid (left panel).
Human liver sections were used as control (right panel). The arrows point to Ki67-positive cells in the liver. Scale bars equal 100 μm (original magnification:
400x).C) The expression levels of the hepatocyte polarization markers E-Cadherin and ZO–1 as well as albumin were further analyzed by real-time PCR in
samples from 10-day LOs (the average value of 4 different LOs +/-SD is shown). For comparison samples from four different donors were analyzed in
parallel. Expression of the house-keeping gene HPRT–1 was used for normalization. pHC = primary hepatocytes (non-cultured).
doi:10.1371/journal.pone.0139345.g005
Generation of 3D Liver Organoids
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upcyte1 hepatocyte strain (Fig 6A). On the mRNA level expressions of five additional drug
metabolizing enzymes (CYPs 2a6, 2d6, 2e1 as well as Sult1a1 and Ugt1a3) were determined by
real-time PCR and were compared to primary human hepatocytes or whole liver from 4 differ-
ent donors (Fig 6B). While there was an expectable variability in the expression levels between
the four donors the levels of expression in the 10-day organoids was mostly within an average
range. This further supports the conclusion that hepatocytes within the organoids are func-
tional cells allowing the use of these structures to analyze e.g. hepatic toxicity of certain sub-
stances or drugs. Comparing the overall architecture of the parenchymal areas within the LO's
with adult human liver we noticed that the cell shape of individual hepatocytes frequently
resembled that of primary cells in the liver (see rectangular frames in Fig 6C) and hepatocytes
often formed circular arrangements of cells, also resembling similar structures of adult liver.
However, the average seize of the nuclei and the relation of nucleus to cytoplasm of the LO-
hepatocytes is different from the adult liver with nuclei being frequently bigger and showing
less cytoplasmic areas (Fig 6C).
Discussion
Shortage of liver for organ transplantation to treat end-stage liver disease and lengthy waiting
lists of organ recipients explains the importance of developing functional liver ex vivo through
tissue engineering [17]. The intention to reduce animal experiments is of high priority and in
addition, animal models can never fully reflect the human cell interactions. Conventional in
vitro systems often lack the necessary cellular cross talk and cells in these systems have often
lost major properties of the corresponding primary cells, which profoundly limits their possible
applications.
In this manuscript we demonstrate that organoid structures with some similarities to adult
liver tissue can be generated in vitro using differentiated adult human cells. Similar structures
were generated earlier by Takebe et al. [5] using endodermal cells derived from induced plurip-
otent stem (iPS) cells combined with HUVECs and mesenchymal stem cells (MSCs). The
authors demonstrated that MSCs play a pivotal role for this three-dimensional structure for-
mation. MSCs are multipotent, self-renewing, adult stem cells, which can differentiate into
hepatocytes (reviewed in [18]). Such differentiation can be induced by addition of growth fac-
tors like hepatocyte growth factor (HGF) or basic fibroblast growth factor (bFGF) [19] or by
co-culturing the cells with hepatocytes [20], [21].
Because MSC-derived hepatocytes acquire the ability to express hepatocyte marker genes
like albumin it would be difficult to distinguish between the original hepatocytes and MSC-
derived hepatocytes in our 10-day organoids, therefore we cannot exclude that at least some of
the hepatocytes in the organoids originated fromMSCs. However, direct differentiation of
MSCs into hepatocytes might not represent the major mechanism how MSCs support survival
of liver tissue as it has been shown that intravenous bolus of conditioned medium fromMSC
can already provide a significant survival benefit in rats undergoing fulminant liver failure
[22]. Therefore the possible hepatoprotective effect of MSCs seems to be mainly based on the
secretion of factors which on the one side may modulate cells of the immune system (which
are not present in our setup) but also exert direct anti-apoptotic effects on hepatocytes [23].
The exact nature of these MSC-derived factors that might be essential for organoid formation
are yet to be explored. However, Takebe et al. have already described that application of inhibi-
tors against bone morphogenetic proteins (BMPs) or fibroblast growth factor (FGF) effectively
prevented the structure formation in their setting [5].
The data presented here demonstrate that differentiated adult upcyte
1
human cells can be
used for the formation of three-dimensional hepatic structures in vitro which are viable and
Generation of 3D Liver Organoids
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Fig 6. Expression and activity of drug metabolizing enzymes. Comparison of 10-day LOs with human liver. A) The basal activities of Cyps 3A4, 2B6
and 2C9 were measured (average of n = 4 +/-SD) in 10-day liver organoids (LOs). LOs were formed as shown in Fig 2 inside a bioreactor (Quasi-vivo
1
System from Kirkstall). Substrate incubation was performed for 60 min on day 10 of culture. CYP-activity was normalized to total protein content of the
organoids. Paired pHC are the same primary hepatocytes which had been upcyted1 and used to form the organoids. Basal CYP activity levels of primary
cells shown in the figure were provided by the manufacturer. For CYP2C9 no value was given (ND, not determined). B) Three more CYPs as well as Sult1a1
and Ugt1a3 were investigated on the mRNA expression level by real-time PCR. The average values of 4 different LOs +/-SD is shown. For comparison RNA
samples from 4 donors were analyzed in parallel. The samples from donor 1–3 were RNAs from hepatocytes which were isolated, frozen down without
primary culture and directly lysed after thawing (pHC; non-cultured cells). The sample from donor 4 represents the total RNA isolated from a piece of whole
liver. Expression of the house-keeping gene HPRT–1 was used for normalization. C)Cross-sections of a 10-day LO (on the left) in direct comparison to adult
human liver (on the right; stained against cytokeratins plus haematoxylin). The rectangles mark representative cells showing the typical cuboidal shape of
polarized hepatocytes. The circles highlight areas where hepatocytes have arranged around circular openings. The scale bar equals 100 μm.
doi:10.1371/journal.pone.0139345.g006
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functional up to a period of 10 days in culture (longer culture times are currently under investi-
gation). Such structures resemble the three-dimensional architecture of the in vivo human liver
better than conventional monolayer cultures consisting of hepatoma cell lines or isolated pri-
mary cells. Also, availability of these primary cells from human sources is rather sporadic and
not accessible for everybody. Apart from this, primary cells show a highly unstable phenotype
in culture and produce very variable results due to donor differences and/or varying effective-
ness of the isolation process itself. Upcyte
1
cell strains which exhibit primary cell phenotypes
can be obtained in large amounts from the same donor which meets the demand for compre-
hensive sets of experiments. Due to the standardized protocol, results obtained with this system
are highly reproducible. The use of such organoid liver structures generated in vitro is therefore
suitable for a large range of applications such as the testing of subchronic or chronic toxicity
caused by slow metabolized compounds and in addition it may help to reduce the number of
animal experiments required for therapeutic drug development in the future.
Our results show that hepatocytes within such organoids express epithelial membrane
markers like E-Cadherin and ZO–1, implying that compared to monolayer cultures they retain
a more polarized morphology. We also show that the cells express albumin and produce several
drug metabolizing enzymes to a degree that is comparable to adult human liver. This demon-
strates that the liver organoids represent a 3D set up which is most likely superior to monolayer
cultures of primary hepatocytes where the cells rapidly lose polarity and enzymatic functional-
ity. Nevertheless, the cells within the organoids showed very high proliferative activity which
might point to the conclusion that after 10 days the structures are still developing and that they
did not (yet) reach a fully differentiated status.
Ongoing experiments aim at further optimizing the parameters for long term culture and
differentiation of liver organoids. Additionally, integration of further liver cell types like Kupf-
fer cells and hepatic stellate cells is planned in order to generate structures which resemble
even more closely the in vivo conditions.
Supporting Information
S1 Fig. Photographs of liver organoids after 24 or 48h. Liver organoid preparation can be
down-scaled from 24-well format to 48- or 96-well plate formats.
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